Nano-amorphous composites of cilostazol-HP-β-CD inclusion complexes: Physicochemical characterization, structure elucidation, thermodynamic studies and in vitro evaluation

Journal of Inclusion Phenomena and Macrocyclic Chemistry

Volumn 81, Issue 1, 2015, Pages 175-191

  Desai, Chirag ^a   Prabhakar, Bala ^a  

^a Shri Vile Parle Kelavani Mandal's Narsee Monjee Institute of Management Studies   (India)

Author keywords

2D ROESY NMR; Biorelevant media; Circular dichroism; Inclusion complex; Nanocomposites; Spray drying; Thermodynamics

Indexed keywords

EID: 84926620282     PISSN: 09230750     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10847-014-0447-x     Document Type: Article

References (55)

1. Chi, W.Y., Milani, R.V., White, C.J.: White, Safety and efficacy of cilostazol in the management of intermittent claudication. Vasc. Health Risk Manag. 4, 1197-1203 (2008)
2. Goto, S.: Cilostazol: potential mechanism of action for antithrombotic effects accompanied by a low rate of bleeding. Atheroscler. Suppl. 6, 3-11 (2005)
3. Okamoto, N., Ito, Y., Nagai, N., Murao, T., Takiguchi, Y., Kurimoto, T., Mimura, O.: Preparation of ophthalmic formulations containing cilostazol as an anti-glaucoma agent and improvement in its permeability through the rabbit cornea. J. Oleo Sci. 59, 423-430 (2010)
4. Adderley, S.P., Joshi, C.N., Martin, D.N., Tulis, D.A.: Phosphodiesterases regulate BAY 41-2272-induced VASP phosphorylation in vascular smooth muscle cells. Front. Pharmacol. 3, 1-23 (2012)
5. Bramer, S.L., Forbes, W.P.: Relative bioavailability and effects of a high fat meal on single dose cilostazol pharmacokinetics. Clin. Pharmacokinet. 37(Suppl. 2), 13-23 (1999)
6. Yoo, H.D., Cho, H.Y., Lee, Y.B.: Population pharmacokinetic analysis of cilostazol in healthy subjects with genetic polymorphisms of CYP3A5, CYP2C19 and ABCB1. Br. J. Clin. Pharmacol. 69, 27-37 (2009)
7. Davis, M.E., Brewster, M.E.: Cyclodextrin-based pharmaceutics: past, present and future. Nat. Rev. Drug Discov. 3, 1023-1035 (2004)
8. Loftsson, T., Duchene, D.: Historical perspectives cyclodextrins and their pharmaceutical applications. Int. J. Pharm. 329, 1-11 (2007)
9. Duchene, D., Wouessidjewe, D., Ponchel, G.: Cyclodextrins and carrier systems. J. Control. Release 62, 263-268 (1999)
10. Del Martin Valle, E.M.: Cyclodextrins and their uses: a review. Process Biochem. 39, 1033-1176 (2004)
11. Thackaberry, E.A., Kopytek, S., Sherratt, P., Trouba, K., McIntyre, B.: Comprehensive investigation of hydroxypropyl methylcellulose, propylene glycol, polysorbate 80, and hydroxypropyl-beta-cyclodextrin for use in general toxicology studies. Toxicol. Sci. 117, 485-492 (2010)
12. Challa, R., Ahuja, A., Ali, J., Khar, R.K.: Cyclodextrins in drug delivery: an updated review. AAPS PharmSciTech. 6, E329-E357 (2005)
13. Patel, S.G., Rajput, S.J.: Enhancement of oral bioavailability of cilostazol by forming its inclusion complexes. AAPS PharmSci-Tech. 10, 660-669 (2009)
14. Zheng, Y., Haworth, I.S., Zuo, Z., Chow, M.S.S., Chow, A.H.: Physicochemical and structural characterization of quercetin-bcyclodextrin complexes. J. Pharm. Sci. 94, 1079-1089 (2005)
15. Chadha, R., Gupta, S., Pissurlenkar, R.R.S., Coutinho, E.C.: Characterization, thermodynamic parameters, molecular modeling and in vivo studies of inclusion complexes of pyrimethamine with native β-cyclodextrin and its derivatives. Int. J. Pharm. Pharm. Sci. 4, 102-112 (2012)
16. Tablet, C., Minea, L., Dumitrache, L., Hillebrand, M.: Experimental and theoretical study of the inclusion complexes of 3-carboxycoumarin acid with b-and 2-hydroxypropyl-β-cyclodextrins. Spectrochim. Acta A: Mol. Biomol. Spectros. 92, 56-63 (2012)
17. Higuci, T., Connors, K.A.: Phase solubility techniques. In: Reiley, C.N. (ed.) Advances in analytical chemistry and instrumentation, pp. 117-212. Wiley-Interscience, New York (1965)
18. Araújo, M.V., Vieira, E.K., Lazaro, G.S., Conegero, L.S., Almeida, L.E., Barreto, L.S., da Costa Jr, N.B., Gimenez, I.F.: Sulfadiazine/hydroxypropyl-beta-cyclodextrin host-guest system: Characterization, phase-solubility and molecular modeling. Bioorg. Med. Chem. 15, 5788-5794 (2008)
19. Jobs, P.: Formation and stability of inorganic complexes in solution. Justus Liebigs Ann. Chem. 9, 113-203 (1928)
20. Berman, H.M., Westbrook, J., Feng, J., Gilliland, G., Bhat, T.N., Weissig, H., Shindyalov, I.N., Bourne, P.E.: The protein data bank. Nucleic Acids Res. 28, 235-242 (2000)
21. Kaur, M., Bhatia, R.K., Pissurlenkar, R.R.S., Coutinho, E.C., Jain, U.K., Katare, O.P., Chandra, R., Madan, J.: Telmisartan complex augments solubility, dissolution and drug delivery in prostate cancer cells. Carbohdr. Polym. 101, 614-622 (2014)
22. Dressman, J.B., Amidon, G.L., Reppas, C., Shah, V.P.: Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms. Pharm. Res. 15, 11-22 (1998)
23. Sadeghi, F., Torab, M., Khattab, M., Homayouni, A., Garekani, H.A.: Improvement of physico-mechanical properties of partially amorphous acetaminophen developed from hydroalcoholic solution using spray drying technique. Iran. J. Basic Med. Sci. 16, 1100-1108 (2013)
24. Li, H.Y., Zhang, F.: Preparation of nanoparticles by spray-drying and their use for efficient pulmonary drug delivery. Methods Mol. Biol. 906, 295-301 (2012)
25. Guterres, S.S., Beck, R.C.R., Pohlmann, A.R.: Spray-drying technique to prepare innovative nanoparticulated formulations for drug administration: a brief overview. Braz. J. Phys. 39, 205-209 (2009)
26. Loftsson, T., Hreinsdottir, D., Masson, M.: Evaluation of cyclodextrin solubilization of drugs. Int. J. Pharm. 302, 18-28 (2005)
27. Loftsson, T., Magnúsdóttir, A., Másson, M., Sigurjónsdó ttir, J.F.: Self-association and cyclodextrin solubilization of drugs. J. Pharm. Sci. 91, 2307-2316 (2002)
28. Rougier, N.M., Cruickshank, D.L., Vico, R.V., Bourne, S.A., Caira, M.R., Bujan, E.I., de Rossi, R.H.: Effect of cyclodextrins on the reactivity of fenitrothion. Carbohydr. Res. 346, 322-327 (2011)
29. Blanco, M., Coello, J., Iturriaga, H., Maspoch, S., Perez-Maseda, C.: Circular dichroism spectra of cyclodextrins-ketoprofen inclusion complexes: Determination of enantiomeric purity. Anal. Chim. Acta 407, 233-245 (2000)
30. Kodaka, M.: Application of a general rule to induced circular dichroism of naphthalene derivatives complexed with cyclodextrins. Phys. Chem. A 102, 8101-8103 (1998)
31. Shah, M.R., Sancheti, P.P., Vyas, V.M., Karekar, P.S., Pore, Y.V.: Proton magnetic resonance (1HNMR) spectroscopy and physicochemical studies of zaleplon-hydroxypropyl-β-cyclodextrin inclusion compounds. Drug Discov. Ther. 4, 70-76 (2010)
32. de Araú jo, M.V.G., Vieira, E.K.B., Lázaro, G.S., Conegero, L.S., Ferreira, O.P., Almeida, L.E., Barreto, L.S., da Costa Jr, N.B., Gimenez, I.F.: Inclusion complexes of pyrimethamine in 2-hydroxypropyl-β-cyclodextrin: characterization, phase solubility and molecular modeling. Bioorg. Med. Chem 15, 5752-5759 (2007)
33. de Araú jo, M.V.G., Vieira, E.K.B., Lázaro, G.S., Conegero, L.S., Ferreira, O.P., Almeida, L.E., Barreto, L.S., da Costa Jr, N.B., Gimenez, I.F.: Sulfadiazine/hydroxypropyl-β-cyclodextrin host-guest system: characterization, phase-solubility and molecular modeling. Bioorg. Med. Chem. 16, 5788-5794 (2008)
34. Sohajda, T., Beni, S., Varga, E., Ivanyi, R., Racz, A., Szente, L., Noszal, B.: Characterization of aspartame-cyclodextrin complexation. J. Pharm. Biomed. Anal. 50, 737-745 (2009)
35. Patel, A.R., Vavia, P.R.: Preparation and evaluation of taste masked famotidine formulation using drug/β-cyclodextrin/polymer ternary complexation approach. AAPS PharmSciTech. 9, 544-550 (2008)
36. Goyal, G., Vavia, P.R.: Complexation approach for fixed dose tablet formulation of lopinavir and ritonavir: an anamolous relationship between stability constant, dissolution rate and saturation solubility. J. Incl. Phenom. Macrocycl. Chem. 73, 75-85 (2012)
37. El-Maradny, H.A., Moratda, S.A., Kamel, O.A., Hikal, A.H.: Characterization of ternary complexes of meloxicam-HPbCD and PVP or L-arginine prepared by the spray-drying technique. Acta Pharm. 58, 455-466 (2008)
38. Sambasevam, K.P., Mohamad, S., Sarih, N.M., Ismail, N.: Synthesis and characterization of the inclusion complex of β-cyclodextrin and azomethine. Int. J. Mol. Sci. 14, 3671-3682 (2013)
39. Mura, P., Adragna, E., Rabasco, A.M., Moyano, J.R., Perez-Martinez, J.I., Arias, M.J., Gines, J.M.: Effect of host cavity size and the preparation method on the physicochemical properties of ibuproxam-cyclodextrin. Drug Dev. Ind. Pharm. 25, 279-287 (1999)
40. Shukla, V., Masareddy, R., Anghore, A., Fakkirappa, V.M.: Influence of β-cyclodextrin complexation on ketoprofen release from matrix formulation. Int. J. Pharm. Sci. Drug Res. 1, 195-202 (2009)
41. Swaminathan, S., Vavia, P.R., Trotta, F., Cavalli, R., Tumbiolo, S., Bertinetti, L., Coluccia, S.: Structural evidence of differential forms of nanosponges of beta-cyclodextrin and its effect on solubilization of a model drug. J. Incl. Phenom. Macrocycl. Chem. 76, 201-211 (2013)
42. Wang, S., Ding, Y., Yao, Y.: Inclusion complexes of fluorofenidone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin. Drug Dev. Ind. Pharm. 35, 808-813 (2009)
43. Perisamy, R., Rajamohan, R., Kothainayaki, S., Sivakumar, K.: Spectral investigation and structural characterization of dibenzalacetone: β-cyclodextrin inclusion complex. J. Mol. Struct. 1068, 155-163 (2014)
44. Jadhav, G.S., Vavia, P.R.: Physicochemical, in silico and in vivo evaluation of a danazol-beta-cyclodextrin complex. Int. J. Pharm. 352, 5-16 (2008)
45. Junquera, E., Aicart, E.: Thermodynamic analysis of the binding of a hepatoprotectant drug, thiotic acid, by beta-cyclodextrin. J. Pharm. Sci. 88, 626-631 (1999)
46. Shinoda, K., Fujihira, M.: The analysis of the solubility of hydrocarbons in water. Bull. Chem. Soc. Jpn 41, 2612-2615 (1968)
47. Marsac, P.J., Rumondor, A.C., Nivens, D.E., Kestur, U.S., Stanciu, L., Taylor, L.S.: Effect of temperature and moisture on the miscibility of amorphous dispersions of felodipine and poly(vinyl pyrrolidone). J. Pharm. Sci. 99, 169-185 (2010)
48. Takeuchi, H., Yasuji, T., Yamamoto, H., Kawashima, Y.: Temperature-and moisture-induced crystallization of amorphous lactose in composite particles with sodium alginate prepared by spray-drying. Pharm. Dev. Technol. 5, 355-363 (2000)
49. Murkipidi, V., Gupta, V., Sihorkar, V.: Efficient throughput method for hygroscopicity classification of active and inactive pharmaceutical ingredients by water vapor sorption analysis. Pharm. Dev. Tech. 18, 348-358 (2013)
50. Jain, A.C., Adeyeye, M.C.: Hygroscopicity, phase solubility and dissolution of various substituted sulfobutylether beta-cyclodextrins (SBE) and danazol-SBE inclusion complexes. Int. J. Pharm. 212, 177-186 (2001)
51. Neoh, T.L., Koecher, K., Reineccius, G., Furuta, T., Yoshii, H.: Dissociation characteristic of the inclusion complex of cyclomaltohexaose (a-cyclodextrin) with 1-methylcyclopropene in response to stepwise rising relative humidity. Carbohydr. Res. 345, 2085-2089 (2010)
52. Sangwai, M., Vavia, P.: Amorphous ternary cyclodextrin nanocomposites of telmisartan for oral drug delivery: Improved solubility and reduced pharmacokinetic variability. Int. J. Pharm. 453, 423-432 (2013)
53. Nicolaides, E., Symillides, M., Dressman, J.B., Reppas, C.: Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm. Res. 18, 380-388 (2001)
54. Zoeller, T., Dressman, J.B., Klein, S.: Application of a ternary HP-β-CD-complex approach to improve the dissolution performance of a poorly soluble weak acid under biorelevant conditions. Int. J. Pharm. 430, 176-183 (2012)
55. Zeng, F., Wang, L., Zhang, W., Shi, K., Zong, L.: Formulation and in vivo evaluation of orally disintegrating tablets of clozapine/hydroxypropyl-β-cyclodextrin inclusion complexes. AAPS PharmSciTech. 14, 854-860 (2013)